METHOTREXATE ORION TABLETS 2.5 MG Singapore - English - HSA (Health Sciences Authority)

methotrexate orion tablets 2.5 mg

orion pharma (sg) pte. ltd. - methotrexate disodium eqv methotrexate - tablet - methotrexate disodium eqv methotrexate 2.5mg

Methotrexate Orion 2.5 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate orion 2.5 mg tablets

orion corporation - methotrexate - tablet - 2.5 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

Methotrexate Orion 10 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate orion 10 mg tablets

orion corporation - methotrexate - tablet - 10 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

CHEXATE methotrexate (as sodium) 10 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

chexate methotrexate (as sodium) 10 mg tablet blister pack

orion pharma (aus) pty limited - methotrexate sodium, quantity: 10.97 mg (equivalent: methotrexate, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose - antineoplastic chemotherapy treatment of breast cancer, gestational choriocarcinoma and in patients with chorioadenoma destruens and hydatidiform mole. palliation of acute and subacute lymphocytic leukaemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias. in combination with corticosteroids, methotrexate may be used for induction of remission. the drug is now most commonly used for the maintenance of induced remissions. chexate is also effective in the treatment of the advanced stages (iii and iv, peters staging system) of lymphosarcoma, particularly in children and in advanced cases of mycosis fungoides. psoriasis chemotherapy (see warnings box and section 4.4) because of the high risk attending to its use, chexate is only indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and / or after dermatologic consu

Methotrexate 2.5mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 2.5mg tablets

orion corporation - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate

Methotrexate 10 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 10 mg tablets

orion corporation - methotrexate - tablet - 10 milligram(s) - other immunosuppressants; methotrexate